EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Guava Byproducts (Psidium guajava L.) as a Source of Phenolic Compounds with In Vitro Antihyperlipidemic Potential

Ramiro Baeza-Jiménez iD, Juan Antonio Noriega-Rodríguez iD, Mónica A Villegas-Ochoa iD, Gustavo A Gonzalez-Aguilar iD, Leticia X López-Martínez iD

Molecules · 13.05.2026 · 31 (10) · 1647

DOI: 10.3390/molecules31101647 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, online erschienen am 13.05.2026. Verfasst von Ramiro Baeza-Jiménez und 4 weiteren Autor:innen. Beteiligte Einrichtung: Laboratorio de Biotecnología y Bioingeniería, Centro de Investigación en Alimentación y Desarrollo, A.C. Av. Cuarta Sur 3820, Fracc. Vencedores del D…. Hauptthemen laut MEDLINE: Psidium, Phenols, Plant Extracts, Hypolipidemic Agents. Die Arbeit nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Secretaría de Ciencia, Humanidades, Tecnología e Innovación (SECIHTI).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Guava (Psidium guajava L.) processing produces peels, seeds, and residual pulp. Previous studies have shown that this fraction contains a significant amount of bioactive molecules (more than in the pulp), such as phenolic compounds, which have demonstrated health-beneficial bioactivities, including antioxidant, anti-obesogenic, and antihyperlipidemic activities, among others. In this study, we aimed to characterize total phenolic compounds, total flavonoids, the phenolic profile, and the in vitro antioxidant and antihyperlipidemic properties of guava byproduct extracts, which were evaluated for their potential use as functional ingredients. Phenolic analysis indicated the total phenolic content (46.45 mg GAE/g), the total flavonoid content (3.86 mg CE/g), and contents of individual phenolic compounds, namely ellagic, syringic, rutin, luteolin, and kaempferol. The extracts showed good antioxidant activity (236.22, 344.89, and 387.1 µmol TE/100 g for TEAC, DPPH, and FRAP, respectively). Moreover, the extracts could bind bile acids (18.50–40.34%) and reduce cholesterol solubility in artificial micelles (53.0–67.6%). Modest pancreatic lipase inhibition (33.33%), stronger cholesterol esterase inhibitory activities (60.22%), and mild HMG-CoA inhibitory potential (16.90%) were recorded. Guava processing byproducts demonstrate the potential to be considered as value-added ingredients in functional foods.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PsidiumPhenolsPlant ExtractsHypolipidemic AgentsAntioxidantsFlavonoidsLipaseBiphenyl Compounds

Stichwörter der Autor:innen

Psidium guavaantioxidant activitycholesterolphenolic compounds

Substanzen

PhenolsAntioxidantsPlant ExtractsHypolipidemic AgentsFlavonoidsLipaseBiphenyl Compounds

Autor:innen und Institutionen

  • Laboratorio de Biotecnología y Bioingeniería, Centro de Investigación en Alimentación y Desarrollo, A.C. Av. Cuarta Sur 3820, Fracc. Vencedores del Desierto, Delicias 33089, Chihuahua, Mexico.
  • Departamento de Ingeniería Química y Metalúrgica, Universidad de Sonora, Blvd. Luis Encinas y Rosales s/n, Col. Centro, Hermosillo 83000, Sonora, Mexico.
  • Coordinación de Tecnología de Alimentos de Origen Vegetal, Centro de Investigación en Alimentación y Desarrollo (CIAD), A. C. Carretera Gustavo Enrique Astiazarán Rosas No. 46, La Victoria, Hermosillo 83304, Sonora, Mex…
  • Laboratorio de Antioxidantes y Alimentos Funcionales, SECIHTI-Centro de Investigación en Alimentación y Desarrollo, A.C. Carr. Gustavo Enrique Astiazarán Rosas 46, Col. La Victoria, Hermosillo 83304, Sonora, Mexico.

ORCID-Profile: Ramiro Baeza-Jiménez, Juan Antonio Noriega-Rodríguez, Mónica A Villegas-Ochoa, Gustavo A Gonzalez-Aguilar, Leticia X López-Martínez

Förderung

  • Secretaría de Ciencia, Humanidades, Tecnología e Innovación (SECIHTI)

Zitieren

APA

Baeza-Jiménez, R., Noriega-Rodríguez, J. A., Villegas-Ochoa, M. A., Gonzalez-Aguilar, G. A., & López-Martínez, L. X. (2026). Guava Byproducts (Psidium guajava L.) as a Source of Phenolic Compounds with In Vitro Antihyperlipidemic Potential. Molecules, 31(10), 1647. https://doi.org/10.3390/molecules31101647

Vancouver

Baeza-Jiménez R, Noriega-Rodríguez JA, Villegas-Ochoa MA, Gonzalez-Aguilar GA, López-Martínez LX. Guava Byproducts (Psidium guajava L.) as a Source of Phenolic Compounds with In Vitro Antihyperlipidemic Potential. Molecules. 2026;31(10):1647. doi:10.3390/molecules31101647

BibTeX
@article{BaezaJimnez2026,
  author = {Baeza-Jiménez, Ramiro and Noriega-Rodríguez, Juan Antonio and Villegas-Ochoa, Mónica A and Gonzalez-Aguilar, Gustavo A and López-Martínez, Leticia X},
  title = {Guava Byproducts (Psidium guajava L.) as a Source of Phenolic Compounds with In Vitro Antihyperlipidemic Potential},
  journal = {Molecules},
  year = {2026},
  volume = {31},
  number = {10},
  pages = {1647},
  doi = {10.3390/molecules31101647}
}
Kostenlos starten →